User menu

The Nootropic Concept and its Prospective Implications

Bibliographic reference Giurgea, CE.. The Nootropic Concept and its Prospective Implications. In: Drug Development Research, Vol. 2, no. 5, p. 441-446 (1982)
Permanent URL http://hdl.handle.net/2078.1/57122
  1. : Animal models of age-related cognitive impairments. In: “Abstr. of the XIIth CINP Congress, Goteborg, Sweden, 22-26 June 1980.” Elmsford, NY: Pergamon Press, 1980, pp. 72-73.
  2. Beart, J. Neurochem., 20, 319 (1973)
  3. Buresova, Acta Neurobiol. Exp. (Warsz.), 33, 673 (1973)
  4. Buresova, Psychopharmacology (Berlin), 46, 93 (1976)
  5. : Use of a nootropic substance to increase the capacity for verbal learning and memory in normal man. In: 3rd Congress International College of Psychosomatic Medicine, Rome (Italy), 16-20.9.75. pp. 107-110, 1975.
  6. Dimond, Psychopharmacology (Berlin), 49, 307 (1976)
  7. and : Effects of a nootropic drug in patients affected by hemiplegia after stroke during rehabilitation treatment. In: “Abstr. of the XIIth CINP Congress, Goteborg, Sweden, 22-26 June 1980.” New York: Pergamon Press, 1980, p. 428.
  8. : Vers une pharmacologie de I'activite integrative du cerveau. Tentative du concept nootrope en psychopharmacologie. In: “Actualites Pharmacologieques, 25eme Serie,” Paris: Masson, 1972, pp. 115-156.
  9. Giurgea, Conditional Reflex, 8, 108 (1973)
  10. : Piracetam: Nootropic pharmacology in neurointegrative activity. In and (eds): “Current Developments in Psychopharmacology.” Vol. III. New York: Spectrum Publ., 1976, pp. 223-273.
  11. : Peptides, memory and neuroendocrine correlates. In and (eds): “Neuroendocrine Correlation in Neurology and Psychiatry.” Amsterdam: Elsevier, 1979, pp. 283-292.
  12. : “Fundamentals to a Pharmacology of the Mind.” Springfield, IL: Charles C. Thomas, Publ., 1981, p. 446.
  13. Giurgea, Arch. Int. Pharmacodyn., 166, 238 (1967)
  14. and : Gerontopsychopharmacological agents: Experimental behavioural pharmacology. In (ed): “Handbook of Pharmacology and Geriatric Psychopharmacology.” Berlin/Heidelberg: Springer Verlag, 1981.
  15. and : The pharmacology of callosal transmission: A general survey. In and (eds): “Structure and Function of Cerebral Commissures.” London: McMillan, 1979, pp. 283-298.
  16. Giurgea, Prog. Neuro-Psychopharmacol, 1, 237 (1977)
  17. Gobert, J. Pharm. Belg., 27, 281 (1972)
  18. Greindl, Arch. Int. Pharmacodyn. Ther., 190, 404 (1971)
  19. Moyersoons, Arch. Int. Pharmacodyn., 179, 388 (1969)
  20. Nickolson, Biochem. Pharmacol., 25, 2241 (1976a)
  21. Nickolson, Brain Res., 113, 616 (1976b)
  22. Oosterveld, Arzneim. Forsch. (Drug Res.), 30, 1947 (1980)
  23. Reuse-Blom, Acta Cardiol., 34/2, 35 (1979)
  24. Strubbe, Ind. Chim. Belge, 3/32, 212 (1967)
  25. (36e Congress de Chimie Industrielle, Bruxelles, 1966).
  26. Valzelli, Neuropsychobiol., 6, 224 (1980a)
  27. Valzelli, Int. Pharmacopsychiatry, 15, 150 (1980b)
  28. : Increased verbal learning in dyslexic and control subjects using piracetam (ucb 6215). In “A. P. Report 87-November 1978, University of Aston in Birmingham, College House, Gosta Green, Birmingham, B4 7ET (U.K.)” 1978, pp. 49.
  29. Wilsher, Psychopharmacology, 65, 107 (1979)
  30. Woelk, Arzn. Forsch. (Drug Res.), 29, 615 (1979)
  31. Woelk, Arzn. Forsch. (Drug Res.), 28, 1752 (1978)